Close
Get it on Google Play

FDA Panel Backs Auxilium's (AUXL) XIAFLEX

September 16, 2009 3:07 PM EDT
A FDA panel is backing Auxilium Pharmaceuticals (Nasdaq: AUXL) XIAFLEX drug to treat Dupuytren's contracture, a condition in which connective tissue in the hands hardens and contracts.

An FDA panel voted 12-0 in favor of XIAFLEX, saying it is a safe and effective alterative to surgery, and in some ways may be better than surgery.

Shares of Auxilium have been halted all day ahead of the news.

You May Also Be Interested In





Related Categories

FDA